Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JP Morgan Maintains Neutral on ArcBest, Raises Price Target to $134

Author: Benzinga Newsdesk | August 05, 2024 09:11am
JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $127 to $134.

Posted In: ARCB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist